Broader Measures of Value

While the Quality Adjusted Life Year (QALY) outcome metric is the most commonly used in economic evaluation of health care interventions, it is increasingly recognised as being insensitive, in some contexts, to what is valued by patients and the public. We collaborate with the Methods of Benefit Valuation (MBV) theme to progress the application of broader measures of value in the economic evaluation of health technologies within a cost-benefit analysis (CBA) framework.

Current projects
Recently completed projects
Projects completed 2010-2015
Projects completed before 2010

Current Projects

Recently Completed Projects

Projects completed 2010-2015